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Abstract  
BACKGROUND: Ghrelin is a 28-amino acid peptide that predominantly produced by the stomach. Strong 
evidence indicates the effects of ghrelin in the regulation of metabolic functions and its potential role in the 
aetiology of obesity. 
 
AIM: The aim of this study was to investigate the relationship of ghrelin levels with obesity, insulin resistance and 
glucose in normal and obese subjects. 
METHODS: Thirteen normal (n = 13) and seven (n = 7) obese weight subjects aged 20-22 participated in the 
study. Fasting plasma ghrelin, insulin and glucose levels were measured after overnight fasting. HOMA-IR was 
calculated to evaluate insulin resistance.  
RESULTS: Ghrelin and insulin levels were found to be statistically significantly lower and higher in obese subjects 
(P < 0.001), respectively. Glucose levels were clinically higher in obese subjects but not statistically significant. 
Fasting plasma ghrelin was negatively correlated with BMI (r = -0.77, P < 0.001), fasting insulin levels (r = -0.55, P 
< 0.001) and HOMA-IR (r = -0.66, P < 0.001). There was no correlation between ghrelin and glucose. In multiple 
regression analysis, insulin levels (Beta: -2.66, 95% CI: -2.49, -2.78, P < 0.001) HOMA-IR (Beta: -2.41, 95% CI: -
2.33, -2.55, P < 0.001) and BMI (Beta: -1.77, 95% CI: -1.66, -1.89, P < 0.001) were significant independent 
determinants of fasting ghrelin. 
CONCLUSION: Obese subjects have low fasting ghrelin levels that they are significantly related to insulin 
resistance and body mass index. More prospective studies are needed to establish the role of ghrelin in the 
pathogenesis of human obesity.  
 
 
 
Introduction 
 
Ghrelin is a 28-amino acid that is produced in 
the stomach. Other organs such as liver heart and 
pancreas can also produce ghrelin but in lower levels 
[1]. Strong evidence indicates the effects of ghrelin in 
its potential role in the pathogenesis of obesity, insulin 
resistance (IR) and types 2 diabetes [2]. 
 
More recently, research on ghrelin has 
improved our understanding of the mechanisms 
involve food intake, fat accumulation, and the 
development of other metabolic disturbances [3].
 
The role of ghrelin in the regulation of glucose 
was initially hypothesized after an observation of a 
negative correlation of insulin and ghrelin [4].  
One year later Schofl et al. [5] supported the 
involvement of ghrelin in the development of IR and 
typed two diabetes. Total ghrelin levels have also 
been found to be negatively correlated with IR in 
children and adolescents [6]. 
 
Food intake is the most important factor that 
influences ghrelin levels. Usually, total ghrelin levels 
are rising during the night and decrease after 
breakfast [7]. 
A long-term high fat diet has found to 
reduce plasma total ghrelin levels and stomach 
content [8]. Also, many studies have reported that 
ghrelin levels are negatively associated with body 
mass index (BMI) [9, 10]. 
We hypothesized that obese individuals would 
present with elevated fasting ghrelin levels and there 
is no relationship between ghrelin and insulin levels. 
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Methods 
 
Twenty healthy subjects (13 with normal 
weight and seven obese) participated in the study 
aged 20-22 years old. A detailed medical history was 
taken by the clinic's doctor. Subjects with a medical 
history of liver, renal, or heart or taking any 
medications and supplements were excluded from the 
study. The study received approval from the ethical 
committees of "Zayed University" and "Doctors 
Medical Center" while all subjects signed a consent 
form.
 
Body weight and height were collected for all 
subjects using SECA 600 model while obesity was 
defined as BMI>30 kg/m
2
, according to the criteria of 
International Obesity Task Force [11]. 
Plasma ghrelin, glucose, insulin and C-
reactive protein (CRP) levels were measured in the 
morning after fasting overnight. Blood samples were 
drawn by a certified nurse by venipuncture into 10-ml 
empty evacuated placed on ice tubes. The tubes were 
immediately centrifuged at 2000 x g for 10 min. 
Plasma ghrelin levels were measure with the 
immunochemilunometric assay (IDS, SMBH, 
Germany) with an inter-assay coefficient of 6.2%. 
Plasma glucose levels were measured using a 
hexokinase enzymatic reference method (Cobas, 
Roche USA). Fasting insulin levels were measured 
using ECLIA method (Cobas 6000, Roche, USA) 
while CPR was measure with Immunoturbidimetry 
(Cobas 6000, Roche, USA). HOMA-IR was used to 
evaluate insulin resistance (fasting serum insulin 
(pmol/l) × fasting plasma glucose (mmol l
-1
)/22.5) [12]. 
 
Statistical Analysis 
Fasting levels of ghrelin, glucose and insulin 
were compared by a t-test between normal and obese 
groups. Pearson’s correlations were calculated 
between anthropometric and biochemical variances 
and ghrelin levels. Moreover, the effect of several 
variables on ghrelin concentrations was considered 
with multiple linear regression analysis. In the 
regression model, we verified ghrelin as a dependent 
variable and included weight, BMI, glucose, Insulin, 
glucose and HOMA-IR as independent variables. 
Values with P < 0.05 were considered statistically 
significant. 
 
 
Results 
 
Fasting plasma levels were significantly lower 
in an obese subject compared to normal ones (Table 
1, Figure 1). Also, BMI, plasma insulin and HOMA-IR 
were significantly higher in the obese group (Table1). 

 
Table 1: Baseline characteristics of Normal and Obese 
subjects 
 
 
Normal 
(n = 13) 
 OB 
(n = 7) 
p-value 
Age, y 
Height, cm 
Weight, Kg 
BMI, kg/m^2
 
CRP 
Glucose, mmol/l 
Insulin, pmol/l 
HOMA-IR 
Ghrelin, pg/ml  
210.8 
1598.2 
538.7 
20.63 
1.21.1 
5.16.5 
8.22.7 
1.850.5 
541202 
21.2.07 
1613.7 
79+11 
31.32.1 
2.01.0 
5.56.7 
14.52.3 
3.540.8 
440140 
0.298 
0.183 
0.001* 
0.001* 
0.065 
0.072 
0.041* 
0.004* 
0.002* 
Data is presented as mean  SD; *P < 0.05 = Statistically significantly difference. 
 
 Fasting plasma ghrelin was negatively 
correlated with BMI (r= -0.77, P<0.001), fasting insulin 
levels (r= -0.55, P < 0.001) and HOMA-IR (r = -0.66, P 
< 0.001). There was no correlation between ghrelin 
and glucose (Table 2). 
 
Figure 1: Ghrelin levels of obese subjects were statistically 
significant compare to normal ones (P < 0.005) 
 
In multiple regression analysis, insulin levels 
(Beta: -2.66, 95% CI: -2.49, -2.78, P < 0.001) HOMA-
IR (Beta: -2.41, 95% CI: -2.33, -2.55, P < 0.001) and 
BMI (Beta: -1.77, 95% CI: -1.66, -1.89, P < 0.001) 
were significant independent determinants of fasting 
ghrelin (Table 3). 
Table 2: Pearson’s Correlation between Ghrelin and other 
variables       
 r p-value 
Age  
Height 
0.51 
-0.34 
0.332 
0.566 
Weight  -0.78 0.002* 
BMI  -0.77 0.001* 
Glucose -0.51 0.455 
Insulin -0.55 0.001* 
HOMA-IR -0.66 0.001* 
*P<0.05: Statistically significant. 
 
Discussion 
In our study contrary to our hypothesis, obese 
subjects have lower concentrations of ghrelin and 
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higher insulin levels that the age-matched lean control 
subjects. This is an indication that ghrelin is 
downregulated in human obesity. This result may be 
because of elevated insulin levels since ghrelin levels 
were independently associated with insulin and 
HOMA-IR. These findings are in agreement with other 
research studies [13, 14]. Ghrelin was shown to 
inhibit insulin secretion from pancreatic islets in 
rodents [15].  
Table 3: Multiple regression analysis of Ghrelin with 
anthropometric and biochemical variables 
Variable Beta 95% CI P 
Weight -0.44 -0.32, -0.55 0.505 
BMI -1.77 -1.66, -1.89 0.001* 
Glucose -0.32 -0.37, -0,49 0.668 
Insulin -2.66 -2.49, -2.78 0.001* 
HOMA-IR -2.41 -2.33, -2.55 0.001* 
*p < 0.05: Statistically significant. 
 
 
Ghrelin secretion may be affected by 
adiposity through insulin and glucose metabolism 
[16]. Studies performed in humans demonstrated 
that i.v. Administration of insulin induces a fall in 
ghrelin levels [17]. Thus, reduced ghrelin levels in 
obesity may be the consequence of increased 
insulin levels in these subjects. 
In our study, ghrelin levels were negatively 
correlated with body weight and independently 
associated with BMI. Research evidence shows that 
plasma ghrelin levels are negatively correlated with 
body mass index and body fat percentage [18]. Also, 
reduced ghrelin secretion in obese patients was found 
to be an adaptive mechanism to a long-term positive 
energy balance [19]. 
The present study has some limitations that 
should be addressed. The small sample of the study 
has an important influence on the results. Also, we did 
not take in consideration any dietary habits, genetic 
information and socioeconomic factors that could also 
play an important role in obesity. Moreover, this was a 
one-time measure and may not represent the reality of 
the indices. Nevertheless, the results will provide 
some evidence of the relation of fasting ghrelin levels 
with insulin resistance and give some light on the 
pathogenesis of human obesity.
 
In conclusion, Ghrelin is deregulated in 
obesity and associated with insulin and insulin 
resistance and thus may be considered a suitable 
target for the management of insulin resistance. 
More studies are needed to elucidate the effects of 
ghrelin in the pathogenesis of human obesity. 
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